Filter
453
Text search:
registered
pharmaceutical
product
Featured
Recommendations
37
New Publications
134
Language
Document type
No document type
264
Studies & Reports
69
Guidelines
65
Manuals
26
Strategic & Response Plan
13
Training Material
7
Fact sheets
5
Situation Updates
3
Resource Platforms
1
Countries / Regions
Kenya
24
Ethiopia
21
South Africa
19
Nigeria
16
Uganda
16
India
16
Tanzania
15
Liberia
14
Malawi
13
Zimbabwe
12
Sierra Leone
11
Ghana
11
Rwanda
11
Namibia
9
Zambia
8
Western and Central Europe
8
Global
8
Bangladesh
7
Eswatini/ Swaziland
7
Nepal
6
Botswana
6
Philippines
5
Lesotho
5
Cambodia
4
Indonesia
4
Ukraine
4
Myanmar / Burma
4
Senegal
3
Haiti
3
Syria
3
Eastern Europe
3
Albania
3
Sudan
2
Benin
2
North Macedonia
2
Latin America and the Carribbean
2
United Kingdom
2
Burkina Faso
1
Congo, Democratic Republic of
1
Cameroon
1
Pakistan
1
South Sudan
1
Jordan
1
Thailand
1
China
1
Ireland
1
Mozambique
1
Central African Republic
1
Libya
1
Angola
1
South–East Asia Region
1
Asia
1
Africa
1
Venezuela
1
Russia
1
Bulgaria
1
Moldova
1
Iran
1
Australia
1
North America
1
Denmark
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
258
Clinical Guidelines
21
Pharmacy & Technologies
19
Key Resources
18
Public Health
10
Capacity Building
5
Women & Child Health
5
Toolboxes
Pharmacy
64
AMR
42
TB
24
HIV
20
COVID-19
15
Mental Health
14
NTDs
10
Conflict
7
Caregiver
6
Global Health Education
5
Disability
3
Rapid Response
3
Planetary Health
3
Malaria
3
Specific Hazards
2
Health Financing Toolbox
2
Ebola & Marburg
1
Cholera
1
Polio
1
Refugee
1
NCDs
1
2.0 Rapid Response
1
This new edition and fully updated publication replaces the 2012 UCG and is being circulated free of charge to all public and private sector prescribers, pharmacists, and regulatory authorities in the country
"This document has been developed for outpatient oncology
facilities to serve as a model for a basic infection
control and prevention plan. It contains policies
and procedures tailored to these settings to meet minimal
expectations of patient protections as described
in the CDC Guide to Infecti
...
Mission report: June 11-20, 2017
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f
...
The classification of digital health interventions (DHIs) categorizes the different ways in which digital and mobile technologies are being used to support health system needs. Historically, the diverse communities working in digital health—including government stakeholders, technologists, clinic
...
This short paper aims to identify key evidence gaps in our knowledge of livestock- and fisheries-linked antimicrobial resistance in the developing world, and to document on-going or planned research initiatives on this topic by key stakeholders.
The antimicrobial resistant (AMR) infections in anima
...
Bangladesh Health Facility Survey 2014
recommended
Final Report
This is an update of a seven-year TB and Leprosy national strategic plan (TBL-NSP), which extends from 2013 to 2020. The update focuses on the plan covering from 2017-20 and is based on the 2017 external mid-term programme review key findings and recommendations; the global and national End TB strat
...
This handbook reflects and updates the work that ECLAC has done in recent decades to establish a methodology for estimating the economic consequences of a disaster, and thus determine the financing required to rebuild and return the affected area to normal. The handbook's third edition strengthens p
...
